Table 1 Patient characteristics.
Female gender | % | 53.6 |
Age (years) | Median (IQR) | 66 (58–76) |
BMI (kg/m2) | Median (IQR) | 27.9 (24.9–32.0) |
ASA | ||
I | n (%) | 24 (7.8) |
II | n (%) | 214 (69.5) |
III | n (%) | 66 (21.4) |
IV | n (%) | 3 (1.0) |
MET | ||
< 5 | n (%) | 126 (46.7) |
≥ 5 | n (%) | 144 (53.3) |
Surgery | ||
Total hip arthroplasty | n (%) | 202 (65.6) |
Total knee arthroplasty | n (%) | 79 (25.6) |
unicondylar arthroplasty | n (%) | 25 (8.1) |
Wave | n (%) | 2 (0.6) |
Anticoagulation | ||
No anticoagulation | n (%) | 221 (71.8) |
Platelet inhibitor | n (%) | 49 (15.9) |
DOAC | n (%) | 27 (8.8) |
Phenprocoumon | n (%) | 11 (3.6) |
Drain inserted | n (%) | 136 (44.2) |
Use of tranexamic acid | n (%) | 118 (38.3) |